🔬 Radiofrequency + IPL for Dry Eye Disease: The Complete Guide to Choosing the Best RF Device for Your Practice (2026)
If you follow my blog or podcast, you know I'm passionate about staying on the cutting edge of dry eye treatment. Today I'm sharing my deep dive into radiofrequency (RF) devices for dry eye disease — specifically, which RF devices can be used before or alongside intense pulsed light (IPL) therapy to maximize outcomes for our meibomian gland dysfunction (MGD) patients.
The evidence is clear: combining RF with IPL delivers superior results compared to either modality alone. A 2023 clinical study by Chelnis et al. showed that multi-frequency RF combined with IPL and meibomian gland expression resulted in a 150% average increase in expressible meibomian glands, over 70% improvement in meibum clarity, and greater than 60% symptom improvement (PMID: 37881780).
So the question isn't whether to add RF to your dry eye practice — it's which device makes the most sense.
Why Add RF to Your IPL Protocol?
Radiofrequency and IPL work through complementary mechanisms to tackle MGD from different angles. IPL uses broad-spectrum light to reduce periocular inflammation by targeting abnormal blood vessels, decreasing inflammatory cytokines, and eliminating Demodex mites. RF, on the other hand, delivers controlled thermal energy directly to the eyelid tissue, heating and liquefying thickened meibum within blocked glands while simultaneously stimulating collagen production and improving blood circulation.
When you perform RF before IPL, you effectively "pre-treat" the meibomian glands — warming and softening the inspissated meibum so that when you follow with IPL (which further reduces inflammation) and then meibomian gland expression, you get dramatically better meibum expression and longer-lasting results.
Step 1: Radiofrequency to periorbital skin (6–15 min) → Heats meibomian glands, softens meibum, stimulates collagen
Step 2: IPL to lower face/periorbital area (10–15 min) → Reduces inflammation, targets blood vessels, kills Demodex
Step 3: Meibomian gland expression (5–10 min) → Clears softened, liquefied meibum from glands
Schedule: 4 treatments at 2-week intervals, then maintenance every 6–12 months
📊 CHART 1: RF + IPL Combination Devices for Dry Eye
FDA-cleared devices listed first. Since we currently have a Lumenis IPL machine, compatibility is a key factor.
| Device / Platform | Manufacturer | FDA Status | RF Type | Cost (RF Component) | Works with Our Lumenis IPL? | Patient Cost / Session | Protocol |
|---|---|---|---|---|---|---|---|
| ★ Lumenis OptiPLUS | Lumenis | FDA-Cleared | Dual-frequency RF (1 + 4 MHz) | $15,000–$25,000 | ✅ YES — designed as companion to OptiLIGHT | $600-$800 (RF+IPL) | 4 sessions / 2-week intervals; maintenance q6–12mo |
| ★ InMode Envision (Forma-I + Lumecca-I) | InMode | FDA-Cleared | Bipolar RF | $75,000–$120,000 (full platform) | ❌ NO — separate platform, would replace our IPL | $600-$800 (RF+IPL) | 4–6 weekly sessions; maintenance q4–6mo |
| ★ Cynosure TempSure Envi (eyeEnvi) | Cynosure / Lutronic | FDA-Cleared (off-label for MGD) | Monopolar RF 4.0 MHz, 300W | $40,000–$65,000 (platform) | ⚠️ Separate device — can pair with existing IPL | $300–$600 RF; $700-$1000 combo | 3–5 weekly sessions; maintenance q3–6mo |
| Eye-Light (LLLT, not RF) | Topcon | Not FDA for DED | LLLT + IPL (not RF) | $50,000–$80,000 | ❌ Different technology | $450–$600 | 4 sessions q2–3 weeks; maintenance q6–12mo |
📊 CHART 2: RF-Only Devices (No Built-in IPL) — FDA Status, Treatment Costs, and Frequency
| RF Device | FDA Cleared for DED? | Avg Cost per RF-Only Treatment | Avg Cost per RF + IPL Treatment | Treatment Frequency |
|---|---|---|---|---|
| ★ Lumenis OptiPLUS | ✅ FDA-Cleared | $300–$500 | $500–$700 | 4 sessions at 2-wk intervals → maintenance q6–12mo |
| ★ InMode Forma-I | ✅ FDA-Cleared (periorbital) | $350–$650 | $500–$900 | 4–6 weekly sessions → maintenance q4–6mo |
| ★ Cynosure TempSure eyeEnvi | ✅ FDA-Cleared (wrinkles; off-label MGD) | $300–$600 | $500–$1000 | 3–5 weekly sessions → maintenance q3–6mo |
| Thermaeye Plus | CE Mark only (not US) | $200–$500 | $400–$700 | 3–4 sessions q2–4wks → maintenance q6mo |
| IProX (simultaneous RF+IPL) | Not FDA-cleared for DED | N/A (combined) | $350–$700 | 4 sessions q2–4wks → maintenance q6–12mo |
💰 Machine Purchase Cost Comparison
| Device | Estimated Machine Cost | Add-On to Existing System? | Per-Treatment Disposables | Approx Break-Even |
|---|---|---|---|---|
| Lumenis OptiPLUS | $15,000–$25,000 | ✅ YES — adds to your OptiLIGHT | ~$10–$50/treatment (electrodes) | ~50–80 treatments |
| InMode Forma-I (handpiece only) | $8,000–$15,000 | Only if you own InMode base unit | Minimal | ~30–50 treatments |
| Cynosure TempSure Envi (full) | $40,000–$65,000 | ❌ Standalone platform | ~$5/treatment (grounding pads) | ~100–180 treatments |
| InMode Envision (full platform) | $75,000–$120,000 | ❌ Complete platform (RF + IPL + microneedling) | Tips/filters | ~200–300 treatments |
⭐ My Recommendation for Our Practice
Since we already own the Lumenis OptiLIGHT IPL, the clear winner is the Lumenis OptiPLUS:
✅ Lowest cost — $15K–$25K as an add-on (vs. $40K–$120K for alternatives)
✅ Designed specifically to integrate with our existing OptiLIGHT
✅ FDA-cleared with the strongest published clinical data (PMID: 37881780)
✅ Fast treatment time — approximately 6 minutes per side
✅ Dual-frequency RF (1 MHz superficial + 4 MHz deep) reaches different tissue layers
✅ Aesthetic bonus — collagen stimulation for periorbital skin rejuvenation
✅ Quickest ROI — break-even at approximately 50–80 treatments
The only scenario where I'd consider the InMode Envision is if we were starting from scratch without any IPL device, or if we wanted to add RF microneedling (Morpheus8) for aesthetic cases.
The Clinical Evidence: What the Studies Show
The landmark 2023 study by Chelnis, Garcia, and Hamza (published in Clinical Ophthalmology) evaluated 31 patients with moderate-to-severe DED due to MGD. Patients received 4 treatments at 2-week intervals consisting of IPL followed by multi-frequency RF on the periocular skin, followed by meibomian gland expression. The results were striking: the modified Meibomian Gland Score improved significantly from baseline to follow-up (p < 0.0001), OSDI symptom scores improved over 60%, and the number of expressible glands increased by more than 150%. Meibography also showed improvement in gland area loss, suggesting possible gland regeneration.
A complementary 2023 ARVO presentation showed that combined IPL and RF treatment produced objective improvement on meibography — with one remarkable case showing meibomian gland area loss decrease from 47.3% to just 5.0% — providing evidence that these treatments may actually help regenerate gland tissue, not just improve existing function.
The 2022 randomized controlled trial by Toyos et al. (PMID: 35737696) demonstrated that IPL plus meibomian gland expression significantly improved tear break-up time, meibum quality, and the number of expressible glands compared to sham treatment, establishing the foundation for adding RF as an additional synergistic modality.
• RF and IPL for dry eye are NOT covered by insurance — these are cash-pay procedures
• CPT code 17999 (unlisted skin procedure) is commonly used for billing
• Always perform a comprehensive dry eye workup including meibography before recommending treatment
• Machine costs are estimates based on industry sources and may vary by region and negotiation
• Contact manufacturers directly for current pricing quotes
Bottom Line for Eye Care Practitioners
If you already own a Lumenis IPL, adding the OptiPLUS RF is a no-brainer — low cost of entry, strongest published evidence, seamless integration, and a quick path to ROI. If you're starting fresh, the InMode Envision offers the most comprehensive platform. And if budget is tight but you want RF capability, a standalone TempSure Envi can pair with any existing IPL system.
The future of dry eye treatment is multimodal. RF + IPL + meibomian gland expression gives our patients the best shot at meaningful, lasting relief.
Have questions? Leave a comment below or reach out to me on The Eye Show podcast!
📚 Verified PubMed References
1. Chelnis J, Garcia CN, Hamza H. Multi-Frequency RF Combined with Intense Pulsed Light Improves Signs and Symptoms of Dry Eye Disease Due to Meibomian Gland Dysfunction. Clin Ophthalmol. 2023;17:3089-3102. PMID: 37881780
2. Toyos R, Desai NR, Dell SJ. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. PLoS One. 2022;17(6):e0270268. PMID: 35737696
3. Zhang Y, et al. Effect of Intense Pulsed Light Therapy in Dry Eye Disease Caused by Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis. Photobiomodul Photomed Laser Surg. 2022;40(10):658-667. PMID: 36044829
4. Cote S, et al. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev. 2020;3(3):CD013559. PMID: 32182637
5. Li J, et al. Efficacy and safety of Intense pulsed light therapy for dry eye caused by meibomian gland dysfunction: a randomised trial. Ann Palliat Med. 2021;10(7):7857-7865. PMID: 34353073
6. Javate RM, Cruz RT Jr, Khan J, Trakos N, Gordon RE. Nonablative 4-MHz dual radiofrequency wand rejuvenation treatment for periorbital rhytides and midface laxity. Ophthalmic Plast Reconstr Surg. 2011;27(3):180-185. PMID: 21283035
7. Chelnis J, et al. Effects of IPL and RF treatment on meibomian gland regeneration and patient experience of dry eye disease. IOVS. 2023;64(8):4819. (ARVO 2023 Abstract)
8. Han JY, et al. Safety and efficacy of a low-level radiofrequency thermal treatment in an animal model of obstructive meibomian gland dysfunction. Lasers Med Sci. 2022;37(6):2595-2602. PMID: 35292578
9. Fineide F, et al. Intense pulsed light treatment in meibomian gland dysfunction: Past, present, and future. Acta Ophthalmol. 2024;102(2):e135-e158. doi:10.1111/aos.15759
10. Patil S, Sawale G, Ghuge S, Sathaye S. Quintessence of currently approved and upcoming treatments for dry eye disease. Graefes Arch Clin Exp Ophthalmol. 2025;263(2):269-278. PMID: 39215848
Disclaimer: Machine costs are estimates based on publicly available information and industry sources as of February 2026. Actual pricing varies by region, negotiation, and purchase agreements. Contact manufacturers directly for current quotes. This blog post is for educational purposes and does not constitute a product endorsement. Dr. Cremers has no financial conflicts of interest with any of the manufacturers listed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.